Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.91 USD | -1.69% | -3.02% | -6.11% |
Jun. 04 | AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders. | CI |
Jun. 03 | After trial, investors weigh Trump 2.0 factor as election looms | RE |
Financials (USD)
Sales 2024 * | 1.62B | Sales 2025 * | 1.68B | Capitalization | 2.61B |
---|---|---|---|---|---|
Net income 2024 * | 300M | Net income 2025 * | 321M | EV / Sales 2024 * | 1.61 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
8.97
x | P/E ratio 2025 * |
8.16
x | Employees | 2,025 |
Yield 2024 * |
5.56% | Yield 2025 * |
3.93% | Free-Float | 81.72% |
Latest transcript on Federated Hermes, Inc.
1 day | -1.69% | ||
1 week | -3.02% | ||
Current month | -4.16% | ||
1 month | -3.34% | ||
3 months | -10.98% | ||
6 months | -3.43% | ||
Current year | -6.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 75 | 71-12-31 | |
Thomas Donahue
DFI | Director of Finance/CFO | 65 | 98-04-30 |
Compliance Officer | 49 | 11-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 75 | 71-12-31 | |
Thomas Donahue
DFI | Director of Finance/CFO | 65 | 98-04-30 |
John Fisher
BRD | Director/Board Member | 67 | 98-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 415 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 31.79 | -2.06% | 171 455 |
24-06-12 | 32.46 | +0.06% | 664,285 |
24-06-11 | 32.44 | -0.18% | 1,292,248 |
24-06-10 | 32.5 | -0.43% | 854,749 |
24-06-07 | 32.64 | -0.43% | 1,311,387 |
Delayed Quote Nyse, June 13, 2024 at 12:25 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.11% | 2.61B | |
+32.82% | 98.94B | |
-6.67% | 93.71B | |
+10.91% | 26.77B | |
-1.92% | 14.53B | |
+2.35% | 14.13B | |
-26.05% | 11.88B | |
+24.68% | 10.24B | |
+15.13% | 9.18B | |
+19.73% | 6.71B |
- Stock Market
- Equities
- FHI Stock